X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
oncology (10) 10
breast cancer (9) 9
trastuzumab (9) 9
chemotherapy (8) 8
cancer (6) 6
hematology, oncology and palliative medicine (6) 6
humans (6) 6
adult (5) 5
female (5) 5
middle aged (5) 5
aged (4) 4
breast neoplasms - drug therapy (4) 4
monoclonal-antibody (4) 4
receptor, erbb-2 - metabolism (4) 4
safety (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
breast neoplasms - pathology (3) 3
efficacy (3) 3
erbb-2 protein (3) 3
her2 (3) 3
open-label (3) 3
patients (3) 3
plus (3) 3
research (3) 3
survival (3) 3
therapy (3) 3
trastuzumab - administration & dosage (3) 3
trastuzumab - adverse effects (3) 3
adjuvant chemotherapy (2) 2
adjuvant treatment (2) 2
aged, 80 and over (2) 2
analysis (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
body weight (2) 2
breast neoplasms - blood (2) 2
breast neoplasms - metabolism (2) 2
care and treatment (2) 2
clinical trials (2) 2
doxorubicin (2) 2
epidermal growth factor (2) 2
gastric cancer (2) 2
hannah (2) 2
heart (2) 2
her2-positive (2) 2
herceptin (2) 2
metastatic breast-cancer (2) 2
neoplasm staging (2) 2
pertuzumab (2) 2
phase-ii (2) 2
prefher (2) 2
safety and security measures (2) 2
treatment outcome (2) 2
abridged index medicus (1) 1
adenocarcinoma (1) 1
adjuvant (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - pharmacokinetics (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic agents, immunological - adverse effects (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
article (1) 1
asian population (1) 1
autoimmune diseases (1) 1
autoimmunity (1) 1
biomarkers (1) 1
biomarkers - blood (1) 1
biomarkers, tumor - analysis (1) 1
breast (1) 1
breast neoplasms - chemistry (1) 1
brief report (1) 1
cancer patients (1) 1
cancer therapies (1) 1
capecitabine (1) 1
cardiotoxicity - blood (1) 1
cardiotoxicity - etiology (1) 1
cardiotoxicity - physiopathology (1) 1
cells (1) 1
chemotherapy, adjuvant (1) 1
chemotherapy, adjuvant - methods (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
clinical outcomes (1) 1
clinical-trials (1) 1
cohort studies (1) 1
combination (1) 1
congestive heart failure (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Fountzilas, G and Gogas, H and Pavlidis, N and Eleftheraki, A and Skarlos, D and Koutras, A and Timotheadou, E and Papandreou, C and Pectasides, D and Dimopoulos, M and Criscitiello, C and Azim, H. A and Agbor-Tarh, D and De Azambuja, E and Piccart, M and Baselga, J and Eidtmann, H and Di Cosimo, S and Bradbury, I and Rubio, I. T and Fedele, P and Nacci, A and Lapolla, A. M and Orlando, L and Schiavone, P and Marino, A and Cinefra, M and Ardizzone, A and De Pasquale, M and Cinieri, S and Hennessy, B and Faratian, D and Ju, Z and Lluch-Hernandez, A and Myhre, S and Gonzalez-Angulo, A. M and Overgaard, J and Alsner, J and Borresen-Dale, A and Mills, G. B and Ciruelos, E and De Velasco, G. A and Gamez, A and Castaneda, C and Sepulveda, J and Ghanem, I and Cortes-Funes, H and Fresno, J. A and Cusumano, P and Generali, D. G and Manso, L and Lifrange, E and Jerusalem, G and Klaase, J and Stork-Sloots, L and Holzik, M. L and Albanell, J and Holt, S and Gligorov, J and Eiermann, W and Svedman, C and Fernando, I. N and Bowden, S. J and Brookes, C and Brunt, A. M and Churn, M and Steven, J. H and Agrawal, R. K and Rea, D and Melichar, B and Stroyakovskiy, D and Ahn, J. S and Kopp, M. V and Srimuninnimit, V and Kunz, G and Li, J and van der Horst, T and Muehlbauer, S and Jackisch, C and Rothe, F and Aura, C. M and Bavington, M and Maetens, M and Rouas, G and Sotiriou, C and Ignatiadis, M and Elkhouly, E. A and Metwally, H. M and Hashem, T. A and Abdalaziz, K. K and Gucalp, A and Gupta, G and Patil, S and Wen, Y. H and Akram, M and Brogi, E and Powell, S and Ho, A and Hudis, C. A and Traina, T. A and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix95 - ix115
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 82, p. 237
Abstract Aim: To assess the safety and tolerability of adjuvant subcutaneous trastuzumab (Herceptin SC, H SC), delivered from an H SC Vial via hand-held... 
Heart | Slopes | Therapy | Intravenous administration | Breast cancer | Congestive heart failure | Patients | ErbB-2 protein | Subgroups | Chemotherapy | Epidermal growth factor | Safety | Hypodermic needles | Trastuzumab | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_8
Journal Article
BMC Cancer, ISSN 1471-2407, 03/2018, Volume 18, Issue 1, pp. 295 - 6
Background: Trastuzumab (Herceptin (R) [H]) is the standard of care for HER2-positive locally advanced/metastatic breast cancer and gastric/gastroesophageal... 
Herceptin | Breast cancer | Gastric cancer | Trastuzumab | HER2-positive | EFFICACY | SAFETY | PHASE-II | MONOCLONAL-ANTIBODY | CHEMOTHERAPY | TRIAL | THERAPY | ONCOLOGY | HER2 | PLUS | Development and progression | Research | Drug therapy | Stomach cancer
Journal Article
Cancer Research, ISSN 0008-5472, 02/2016, Volume 76, Issue 4 Supplement, pp. PD5-01 - PD5-01
Journal Article
Clinical Oncology, ISSN 0936-6555, 2013, Volume 26, Issue 2, pp. 81 - 89
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 02/2019, Volume 39, Issue 2, pp. 797 - 802
Background/Aim: This study sought to determine whether an autoimmune background could identify patients with HER2-positive early breast cancer (EBC) who derive... 
Autoimmunity | Breast cancer | HER2 | Trastuzumab | ADJUVANT CHEMOTHERAPY | CELLS | INNATE | breast cancer | MONOCLONAL-ANTIBODY | IMMUNOLOGY | trastuzumab | DEPENDENT CELLULAR CYTOTOXICITY | TUMOR-INFILTRATING LYMPHOCYTES | IMMUNE-SYSTEM | ONCOLOGY | IN-VIVO | PLUS | Family medical history | Autoimmune diseases | Survival | Patients | ErbB-2 protein | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 15_suppl, pp. 575 - 575
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.